Alzheimer's Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-04-15 ACAD Narrow Range Bar Range Contraction
2021-04-15 ACAD 1,2,3 Retracement Bearish Bearish Swing Setup
2021-04-15 ACAD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 ACIU Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 ADMS Crossed Above 20 DMA Bullish
2021-04-15 ADMS Pocket Pivot Bullish Swing Setup
2021-04-15 ADMS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 ADMS MACD Bullish Signal Line Cross Bullish
2021-04-15 AVXL Lower Bollinger Band Walk Weakness
2021-04-15 AVXL MACD Bearish Centerline Cross Bearish
2021-04-15 BIIB 20 DMA Resistance Bearish
2021-04-15 BIIB Crossed Above 200 DMA Bullish
2021-04-15 BIIB 50 DMA Resistance Bearish
2021-04-15 BIIB Stochastic Buy Signal Bullish
2021-04-15 BLU Cup with Handle Other
2021-04-15 CRTX Crossed Above 50 DMA Bullish
2021-04-15 CYTH Narrow Range Bar Range Contraction
2021-04-15 CYTH NR7 Range Contraction
2021-04-15 DNLI Shooting Star Candlestick Bearish
2021-04-15 DNLI Crossed Above 20 DMA Bullish
2021-04-15 DNLI NR7 Range Contraction
2021-04-15 DNLI Bollinger Band Squeeze Range Contraction
2021-04-15 DNLI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 GLMD MACD Bearish Signal Line Cross Bearish
2021-04-15 IDRA New 52 Week Low Weakness
2021-04-15 IDRA Narrow Range Bar Range Contraction
2021-04-15 IDRA New 52 Week Closing Low Bearish
2021-04-15 ITCI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 ITCI Doji - Bearish? Reversal
2021-04-15 ITCI Shooting Star Candlestick Bearish
2021-04-15 ITCI 20 DMA Resistance Bearish
2021-04-15 ITCI MACD Bullish Signal Line Cross Bullish
2021-04-15 LGND 20 DMA Resistance Bearish
2021-04-15 NAVB NR7 Range Contraction
2021-04-15 NAVB Narrow Range Bar Range Contraction
2021-04-15 NYMX MACD Bullish Signal Line Cross Bullish
2021-04-15 NYMX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 OPK 200 DMA Resistance Bearish
2021-04-15 OPK Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 OPK 20 DMA Resistance Bearish
2021-04-15 PFE Pocket Pivot Bullish Swing Setup
2021-04-15 PFE Upper Bollinger Band Walk Strength
2021-04-15 PRTA Crossed Above 20 DMA Bullish
2021-04-15 SAVA Narrow Range Bar Range Contraction
2021-04-15 SAVA Stochastic Buy Signal Bullish
2021-04-15 VTVT Upper Bollinger Band Walk Strength
2021-04-15 YMTX Stochastic Reached Oversold Weakness
2021-04-15 YMTX NR7-2 Range Contraction
2021-04-15 YMTX NR7 Range Contraction
2021-04-15 YMTX Narrow Range Bar Range Contraction

Recent News for Alzheimer's Disease Stocks

Date Stock Title
Apr 16 PFE Why Fauci Thinks Getting Johnson & Johnson COVID-19 Vaccine 'Back On Track' Soon Is Crucial
Apr 16 ACAD SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) and Encourages Long-Term ACAD Stockholders to Contact the Firm
Apr 15 PFE Pfizer CEO Says a Covid Booster Shot Will Likely Be Needed
Apr 15 BIIB Biogen's TECFIDERA wins approval in China to treat multiple sclerosis
Apr 15 BIIB Biogen Grows Presence in China with the Approval of TECFIDERA® (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis
Apr 15 PFE How Pfizer Makes Money: Oncology, Internal Medicine, and Vaccines
Apr 15 PRTA Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021
Apr 15 PFE Coronavirus update: J&J vaccine pause remains, Oxford studies blood clots and COVID-19 vaccines
Apr 15 ACAD Circling Back On Acadia Pharmaceuticals
Apr 15 PFE How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And Others
Apr 15 PFE More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President
Apr 15 ACAD Acadia shares yet to reflect Nuplazid’s full potential: Cantor
Apr 15 BLU CLASS ACTION UPDATE for BLU, MPLN and LDOS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Apr 15 PFE Pfizer CEO Alfred Bourla says booster COVID-19 shots likely needed - CNBC
Apr 15 PFE Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22
Apr 15 BLU Bellus Health, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit
Apr 15 PFE Blood clot risk significantly higher from COVID-19 than from vaccines
Apr 15 PFE FDA, CDC precaution with vaccine side effects is ‘encouraging’: Doctor
Apr 15 PFE Pfizer CEO Bourla: Vaccine Takers May Require Third Booster Dose
Apr 15 BIIB Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD; however, evidence to support these recommendations is not strong. There are no medications or supplements that have been shown to decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programmes may be beneficial with respect to activities of daily living and can potentially improve outcomes. Behavioural problems or psychosis due to dementia are often treated with antipsychotics, but this is not usually recommended, as there is little benefit with an increased risk of early death.In 2015, there were approximately 29.8 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2015, dementia resulted in about 1.9 million deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.

More about Alzheimer's Disease
Browse All Tags